Scientific article
English

Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting

Published inIntensive care medicine, vol. 41, no. 10, p. 1739-1751
Publication date2015
Abstract

Patients in the intensive care unit (ICU) frequently receive prolonged or even unnecessary antibiotic therapy, which selects for antibiotic-resistant bacteria. Over the last decade there has been great interest in biomarkers, particularly procalcitonin, to reduce antibiotic exposure.

Citation (ISO format)
ALBRICH, Werner C, HARBARTH, Stéphan Juergen. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. In: Intensive care medicine, 2015, vol. 41, n° 10, p. 1739–1751. doi: 10.1007/s00134-015-3978-8
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0342-4642
573views
0downloads

Technical informations

Creation13/10/2015 10:08:00
First validation13/10/2015 10:08:00
Update08/10/2024 09:15:50
Status update08/10/2024 09:15:50
Last indexation31/10/2024 02:07:32
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack